Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 9, 2022

Health Canada approves VBI Vaccines’ PreHevbrio for Hepatitis B

Health Canada has granted approval for VBI Vaccines’ PreHevbrio [3-antigen Hepatitis B Vaccine (Recombinant)] to prevent Hepatitis B virus (HBV) in adults.

Continue
Micrograph of ground glass hepatocytes, as seen in a chronic hepatitis B infection. Credit: Nephron / commons.wikimedia.org.
December 6, 2022

US FDA grants fast track designation for IDEAYA’s uveal melanoma therapy

The US FDA granted fast track designation to study darovasertib in combination with crizotinib to treatment metastatic uveal melanoma. Credit: Filipp Romanovski on Unsplash.
December 5, 2022

EMA validates GSK’s application for myelofibrosis therapy

GSK’s MAA for momelotinib to treat myelofibrosis is based on the data obtained from MOMENTUM trial. Credit: GSK plc.

Contracts

November 18, 2022

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Image: Tenacia will get sole rights to develop and commercialise some formulations of ganaxolone, including the present oral and intravenous (IV) dose formulations. Credit: Pexels från Pixabay.

Harbour BioMed, Moderna partner on immunotherapies development

Kite, Refuge sign license deal for gene expression platform for blood cancers

Bavarian Nordic to supply smallpox and monkeypox vaccine to Switzerland

Deals

Deals December 7, 2022

Caris and Hummingbird Bioscience collaborate to advance anti-HER3 therapy

Pharmaceutical Business Review

Graybug, CalciMedica sign agreement to create new biopharmaceutical company

Curevo Vaccine announces closing of $26m Series A1 round

Jazz and Zymeworks sign license agreement for antibody development

Popular

  1. Moleculin receives Fast Track designation for Glioblastoma Multiforme therapy
  2. Rallybio, AbCellera partner to develop therapeutics for rare diseases
  3. iECURE raises funds to advance gene-editing programmes
  4. Aldeyra seeks NDA approval for dry eye disease treatment in US
  5. USFDA grants fast track designation for Kintara’s breast cancer therapy

PRESS RELEASES

Gerresheimer to Expand Significantly in High Value Solutions and Further Accelerates its Sustainable Profitable Growth
Gerresheimer to Expand Significantly in High Value Solutions and Further Accelerates its Sustainable Profitable Growth
Pharmaceutical Business Review
Join NSF’s Health Sciences Team for World Quality Week and Receive Valuable Resources
Pharmaceutical Business Review
Gerresheimer and Stevanato Group Present EZ-fill Smart™, a New and Innovative Ready-To- Fill Vial Platform
Gerresheimer and Nelson Labs Announce Strategic Alliance Regarding Extractables and Leachables Lab Testing for the Pharmaceutical and Biotech Industries
Gerresheimer and Nelson Labs Announce Strategic Alliance Regarding Extractables and Leachables Lab Testing for the Pharmaceutical and Biotech Industries
RWS to Showcase Solutions During ISPOR EU
RWS to Showcase Solutions During ISPOR EU

Suppliers

Whitepapers

Challenges in Antiviral/Vaccine Development for Respiratory Viruses During Possible Future Pandemics
Challenges in Antiviral/Vaccine Development for Respiratory Viruses During Possible Future Pandemics
Cerba Research Biorepository: Your Gateway to Rapid Specimen Procurement and Analysis
Cerba Research Biorepository: Your Gateway to Rapid Specimen Procurement and Analysis
Processing Peripheral Blood Mononuclear Cells (PBMC) for Clinical Trials
Processing Peripheral Blood Mononuclear Cells (PBMC) for Clinical Trials